Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. | 225 000 | déclaré | 03 juin 2025 | tx 16+413 825−213 825 |
| Processa Pharmaceuticals, Inc. | 72 486 | déclaré | 31 mars 2022 | tx 2+22 600 |
| Gain Therapeutics, Inc. | 15 000 | déclaré | 24 juin 2025 | tx 5+101 000 |
| IMMUNOMEDICS INC | 0 | déclaré | 23 oct. 2020 | tx 10+69 848−69 848 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 24 juin 2025 | GRANT_AWARD | Gain Therapeutics, Inc. | 15 000 | 0.00 USD | deriv |
| 03 juin 2025 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 7.88 USD | deriv |
| 15 août 2024 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 5.58 USD | deriv |
| 09 août 2024 | PURCHASE | Gain Therapeutics, Inc. | 50 000 | 1.00 USD | |
| 24 juin 2024 | GRANT_AWARD | Gain Therapeutics, Inc. | 15 000 | 0.00 USD | deriv |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 50 000 | 1.13 USD | |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 20 492 | 2.44 USD | |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 10 000 | 2.69 USD | |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 133 333 | 2.31 USD | |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 133 333 | 2.31 USD | deriv |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 10 000 | 2.69 USD | deriv |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 50 000 | 1.13 USD | deriv |
| 16 nov. 2023 | EXERCISE | FENNEC PHARMACEUTICALS INC. | 20 492 | 2.44 USD | deriv |
| 23 juin 2023 | GRANT_AWARD | Gain Therapeutics, Inc. | 10 500 | 0.00 USD | deriv |
| 12 juin 2023 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 0.00 USD | deriv |
| 20 sept. 2022 | GRANT_AWARD | Gain Therapeutics, Inc. | 10 500 | 0.00 USD | deriv |
| 14 juin 2022 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 0.00 USD | deriv |
| 01 janv. 2022 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 18 208 | 0.00 USD | deriv |
| 31 mars 2022 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 4 392 | — | |
| 29 juin 2021 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 0.00 USD | deriv |
| 23 oct. 2020 | OTHER | IMMUNOMEDICS INC | 13 516 | — | |
| 23 oct. 2020 | OTHER | IMMUNOMEDICS INC | 3 718 | — | deriv |
| 23 oct. 2020 | OTHER | IMMUNOMEDICS INC | 52 614 | — | deriv |
| 13 août 2020 | GRANT_AWARD | FENNEC PHARMACEUTICALS INC. | 25 000 | 0.00 USD | deriv |
| 18 juin 2020 | GRANT_AWARD | IMMUNOMEDICS INC | 3 718 | 0.00 USD |